World’s First Hectapelx PCR technology for ICU Infections
SES is Patented in 51 Countries Globally, SES Detection rate (Positive) of Samples as Blood – 65%, CSF- 50%, BAL- 95%, Eye Fluids- 35%, Ascetic- 35% & Sensitivity 100%, Specificity 100%, Only lab in INDIA which has NABL Approved panels with LOD, means NO FALSE POSITIVE & NO FALSE NEGATIVE, NO COMMENSALS, NO COLINIZERS & only Lab in India which has 30 plus publications on Indian patients.

Syndrome Evaluation System (SES) – A patented technology comprising rapid Hectaplex amplification and accurate identification of the virulence-associated genes of the causative agents or organisms. This amazingly fast and accurate platform transcends all conventional diagnostic tests and is helpful when organisms are difficult to cultivate or difficult to find. The accurate and rapid identification of the causative agents (4-5 hours of process time) empowers the clinician to initiate targeted therapy and thus save lives and significantly reduce disabilities such as blindness, paralysis, and compromised mental faculties.

The technologies currently available for diagnosis of infections are grossly inadequate to detect early during the illness and institute specific therapy in critical illnesses resulting in loss of function or even loss of life.

THE SES ADVANTAGE
Rapid: Process time of 4-5 hours
Higher Accuracy: detects more numbers than conventional methods if the conventional method detects 10-15% SES can give you a detection of 75%
Cost-effectiveness: Avoids multiple testing and unnecessary investigations and reduces ICU stay
Provides Direct evidence for the presence of infection – detects DNA of pathogens.
Comprehensive: Detects fungi, viruses, parasites, and bacteria in a single test. It also detects uni-microbial or poly-microbial infections.
Rules in or Rules out infections
Helps Cliclinicians save and Prevent Disabilities

THE TECHNOLOGY
The technology involves the location of the genetic material of the causative agent from the given specimen and simultaneous amplification of the “Syndrome Specific Signature genes” of all the probable causative agents, followed by “Syndrome Specific Hybridization”.

The amplification of the gene allows for higher sensitivity of the test and the re-naturation of the amplified signature gene to its chemically identified complementary gene sequence on the SES allows for higher specificity of the test. Simultaneous detection of multiple pathogens allows for early diagnosis of the infection and initiation of therapy. Neuroxon offers SES as hectaplex PCR test Services for various critical illnesses in three verticals – Eye Infections, Brain Infections, Sepsis, or Bloodstream infections.

MAJOR TESTS WE ARE OFFERING NOW –

SES Sepsis Panel +AMR
SES Febrile Neutropenia/ Post Transplant/ Pneumonia/ Myocarditis Panel +AMR
SES Community Acquired Panel/ Hospital Acquired Infection Panel +AMR
SES Invasive Fungal Infections Panel +AMR
SES Respiratory Panel
SES PAN CNS Panel
SES Meningitis Panel
SES Acute Encephalitis Panel
SES Meningo Encephalitis Panel
SES Uveitis Panel
SES PAN Uveitis Panel and many more tests…..